<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-01T20:30:16+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2694】2020 IASLC WCLC大幕即将拉开，大会主席吴一龙教授邀您来参会啦！</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/candPOVrf80ovbfLsE_DPw</id>
    <link href="https://mp.weixin.qq.com/s/candPOVrf80ovbfLsE_DPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>舒心可依患者救助项目 3.98万元封顶且门槛价低，患者可及性更高</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/WWNiZwrVTAeQQimmOOY8NQ</id>
    <link href="https://mp.weixin.qq.com/s/WWNiZwrVTAeQQimmOOY8NQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】2020年度盘点|泌尿系肿瘤免疫治疗进展年度盘点</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/A1n5rU6a2FDenm1vE6wTtA</id>
    <link href="https://mp.weixin.qq.com/s/A1n5rU6a2FDenm1vE6wTtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“泌尿肿瘤免疫治疗系列沙龙”揭开面纱，传递前沿进展，促进免疫治疗规范化</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/i5NZlh7lnDVk5K4SBwsBAw</id>
    <link href="https://mp.weixin.qq.com/s/i5NZlh7lnDVk5K4SBwsBAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2693】年度巨制丨「骨与软组织肿瘤药物盘点」即将重磅上线！</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/KFLgR7RbOSWY4Q5WuJF3zA</id>
    <link href="https://mp.weixin.qq.com/s/KFLgR7RbOSWY4Q5WuJF3zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>直肠癌个体化新辅助治疗的决策：以终为始 分而治之</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/PdCQE37ygn3ABWDfBy6_Hg</id>
    <link href="https://mp.weixin.qq.com/s/PdCQE37ygn3ABWDfBy6_Hg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PFS竟然长达16个月！直肠癌术后肺转移患者，多线治疗后如何优选治疗策略</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/_GnEXIntMHPFukcoSmEb9g</id>
    <link href="https://mp.weixin.qq.com/s/_GnEXIntMHPFukcoSmEb9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧狄沃患者援助方案再更新！年自付费用降幅超75%，多瘤种获益</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/fYHjFu2nR5ve-hCyV8Y9xA</id>
    <link href="https://mp.weixin.qq.com/s/fYHjFu2nR5ve-hCyV8Y9xA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【11】 中国早期乳腺癌卵巢功能抑制临床应用专家共识 (2018年版)解读</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/V-y5GGRfF7NStVW7idrzyg</id>
    <link href="https://mp.weixin.qq.com/s/V-y5GGRfF7NStVW7idrzyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【用“实例”说话】肝癌合并门静脉癌栓，局部联合全身治疗全程管理，生存期已逾15个月</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/u3BTxfVlkCZnjyFDx9x8pQ</id>
    <link href="https://mp.weixin.qq.com/s/u3BTxfVlkCZnjyFDx9x8pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 索凡替尼正式获批，非胰腺神经内分泌瘤斩获新药！</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/0WGhYSc87bcdmfQo2idJEw</id>
    <link href="https://mp.weixin.qq.com/s/0WGhYSc87bcdmfQo2idJEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内第2款CDK4/6抑制剂阿贝西利正式获批上市，晚期激素受体阳性乳腺癌患者选择更加多元化</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/4iTwiYXwaRNkUKXBdcv79Q</id>
    <link href="https://mp.weixin.qq.com/s/4iTwiYXwaRNkUKXBdcv79Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2692】【2020金研奖】周彩存教授：有了靶向治疗，有了免疫治疗，肺癌逐步会成为慢性病</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/V8rqIazeHGODPsqfuGJR8A</id>
    <link href="https://mp.weixin.qq.com/s/V8rqIazeHGODPsqfuGJR8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HOW WE TREAT GIST大型网络云会议暨2020年GIST年终盘点邀请函</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/4veia_vHFoevbyd4WPZHQg</id>
    <link href="https://mp.weixin.qq.com/s/4veia_vHFoevbyd4WPZHQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 | 赵雪峰教授解析：使用伊马替尼之外的多靶点激酶抑制剂用于一线治疗晚期胃肠间质瘤(GIST)患者的结局</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/azc4EYl5LQ61r8cz_DruFA</id>
    <link href="https://mp.weixin.qq.com/s/azc4EYl5LQ61r8cz_DruFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【10】探索OFS跌宕起伏的离奇经历之 INTERGROUP研究解读</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/yj8AA1ckZAQS_CWd74O_ng</id>
    <link href="https://mp.weixin.qq.com/s/yj8AA1ckZAQS_CWd74O_ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2691】硕果累累，全球首款RANKL抑制剂地舒单抗，近日成功进入国家医保！</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/50h-g5Dy71hyfqEMnGLZsQ</id>
    <link href="https://mp.weixin.qq.com/s/50h-g5Dy71hyfqEMnGLZsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王洁教授团队发现新型肺腺癌免疫治疗疗效预测生物标志物</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/koZR7Tox9OWJ_3yVxBPHPw</id>
    <link href="https://mp.weixin.qq.com/s/koZR7Tox9OWJ_3yVxBPHPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】靶向CDK4/6抑制剂一线治疗HR+原发耐药内脏转移乳腺癌患者，假性进展后达到PR，且PFS已超过20个月</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/4WcUNSx_6bPD1MlsfZiq4w</id>
    <link href="https://mp.weixin.qq.com/s/4WcUNSx_6bPD1MlsfZiq4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风骨多美，声势加素丨2020 CSCO《经典型骨肉瘤诊疗指南》巡讲·三亚站隆重落幕！</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/xNtm8-9ygkHdYtGOa7YRIQ</id>
    <link href="https://mp.weixin.qq.com/s/xNtm8-9ygkHdYtGOa7YRIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>